Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial
Titel:
Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial
Auteur:
Mesa, Ruben A Vannucchi, Alessandro M Mead, Adam Egyed, Miklos Szoke, Anita Suvorov, Aleksandr Jakucs, Janos Perkins, Andrew Prasad, Ritam Mayer, Jiri Demeter, Judit Ganly, Peter Singer, Jack W Zhou, Huafeng Dean, James P te Boekhorst, Peter A Nangalia, Jyoti Kiladjian, Jean-Jacques Harrison, Claire N